| Dr Sarah Dross-gonzalez, PSYD, HSPP | |
|
4038 Ridgeview Dr Ste 1, Anderson, IN 46013-9715 | |
| (317) 574-1254 | |
| (317) 674-0060 |
| Full Name | Dr Sarah Dross-gonzalez |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 4038 Ridgeview Dr Ste 1, Anderson, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598980468 | NPI | - | NPPES |
| 300020778 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 20042175A (Indiana) | Primary |
| Entity Name | Aspire Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124016050 PECOS PAC ID: 4486635455 Enrollment ID: O20041015000190 |
News Archive
Researchers and clinicians through a multicenter collaboration have identified a novel multisystem disorder caused by bi-allelic variants in the CCDC47 gene. Their findings are reported in the American Journal of Human Genetics.
The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, continues to drive the global effort to ensure patients receive personalized cancer therapies. A total of 17 abstracts concerning Merck Serono oncology treatments will be presented at the joint 15th Congress of the European Cancer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO), to be held in Berlin from 20-24 September 2009.
› Verified 2 days ago
| Entity Name | Baume Psychological Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811246507 PECOS PAC ID: 2466699822 Enrollment ID: O20130503000070 |
News Archive
Researchers and clinicians through a multicenter collaboration have identified a novel multisystem disorder caused by bi-allelic variants in the CCDC47 gene. Their findings are reported in the American Journal of Human Genetics.
The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, continues to drive the global effort to ensure patients receive personalized cancer therapies. A total of 17 abstracts concerning Merck Serono oncology treatments will be presented at the joint 15th Congress of the European Cancer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO), to be held in Berlin from 20-24 September 2009.
› Verified 2 days ago
| Entity Name | Aspire Indiana Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780068288 PECOS PAC ID: 8921314196 Enrollment ID: O20150902001749 |
News Archive
Researchers and clinicians through a multicenter collaboration have identified a novel multisystem disorder caused by bi-allelic variants in the CCDC47 gene. Their findings are reported in the American Journal of Human Genetics.
The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, continues to drive the global effort to ensure patients receive personalized cancer therapies. A total of 17 abstracts concerning Merck Serono oncology treatments will be presented at the joint 15th Congress of the European Cancer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO), to be held in Berlin from 20-24 September 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Dross-gonzalez, PSYD, HSPP 9615 E 148th St Ste 1, Noblesville, IN 46060-4371 Ph: (317) 574-1254 | Dr Sarah Dross-gonzalez, PSYD, HSPP 4038 Ridgeview Dr Ste 1, Anderson, IN 46013-9715 Ph: (317) 574-1254 |
News Archive
Researchers and clinicians through a multicenter collaboration have identified a novel multisystem disorder caused by bi-allelic variants in the CCDC47 gene. Their findings are reported in the American Journal of Human Genetics.
The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, continues to drive the global effort to ensure patients receive personalized cancer therapies. A total of 17 abstracts concerning Merck Serono oncology treatments will be presented at the joint 15th Congress of the European Cancer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO), to be held in Berlin from 20-24 September 2009.
› Verified 2 days ago
Dr. Gary Frances Meunier, PH.D, HSPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1106 Meridian St, Suite 344, Anderson, IN 46016 Phone: 765-644-8567 Fax: 765-644-8577 | |
Dr. Kikuko Campbell, PH.D., M.P.H., HSPP Psychologist Medicare: Medicare Enrolled Practice Location: 2020 Brown St, Anderson, IN 46016 Phone: 765-641-8389 | |
Melisa Joanne Zehr, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2210 Jackson St, Anderson, IN 46016 Phone: 765-683-3118 | |
Dr. Carrie B. Dixon, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100 W 11th St, Suite 100, Anderson, IN 46016 Phone: 765-643-0181 Fax: 765-643-0181 | |
Dr. Galen Lee Griffith, PH. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1100 E 5th St, Anderson, IN 46012 Phone: 765-641-4744 Fax: 765-641-3810 | |
Lina L Burkhart, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave, Anderson, IN 46016 Phone: 765-641-7499 | |
Suzanne Marie Wiley, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 607 Ironwood Ln, Anderson, IN 46011 Phone: 765-400-5086 |